BioCentury
ARTICLE | Company News

Draxis, Molecular Targeting deal

June 8, 1998 7:00 AM UTC

Molecular Targeting and DRAXF’s Draximage Inc. subsidiary (Kirkland, Quebec) will develop, manufacture and market imaging agents, the first of which is Amiscan, a formulation of 99m Tc-glucarate to d...